CNS or classic drugs for the treatment of pain in functional dyspepsia? A systematic review and meta-analysis of the literature.
暂无分享,去创建一个
[1] M. Camilleri. GASTROENTEROLOGY CLINICS OF NORTH AMERICA Functional Dyspepsia : Mechanisms of Symptom Generation and Appropriate Management of Patients , 2022 .
[2] J. Tack,et al. Mechanisms of serotonergic agents for treatment of gastrointestinal motility and functional bowel disorders , 2007, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[3] K. Chayama,et al. Meta‐analysis of the effects of prokinetic agents in patients with functional dyspepsia , 2007, Journal of gastroenterology and hepatology.
[4] W. Wong,et al. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[5] Timothy P. L. Roberts,et al. Gastric fundic distension activates fronto-limbic structures but not primary somatosensory cortex: A functional magnetic resonance imaging study , 2007, NeuroImage.
[6] José V. Pardo,et al. Functional neuroimaging of gastric distention , 2003, Journal of Gastrointestinal Surgery.
[7] P. Dupont,et al. Regional cerebral blood flow during gastric balloon distention in functional dyspepsia. , 2003, Gastroenterology.
[8] J. Freston,et al. Proton Pump Inhibitors: Effective First-Line Treatment for Management of Dyspepsia , 2007, Digestive Diseases and Sciences.
[9] T. Ohkusa,et al. Effect of a gastro‐protective agent, rebamipide, on symptom improvement in patients with functional dyspepsia: A double‐blind placebo‐controlled study in Japan , 2006, Journal of gastroenterology and hepatology.
[10] S. Flier,et al. Is Functional Dyspepsia of Particular Concern in Women? A Review of Gender Differences in Epidemiology, Pathophysiologic Mechanisms, Clinical Presentation, and Management , 2006, The American Journal of Gastroenterology.
[11] E. Mayer,et al. Review article: modulation of the brain–gut axis as a therapeutic approach in gastrointestinal disease , 2006, Alimentary pharmacology & therapeutics.
[12] K. Hahm,et al. Efficacy and safety of ecabet sodium on functional dyspepsia: a prospective, double-blinded, randomized, multi-center controlled trial. , 2006, World journal of gastroenterology.
[13] Á. Pascual-Leone,et al. Novel Therapeutic Approaches to the Treatment of Chronic Abdominal Visceral Pain , 2006, TheScientificWorldJournal.
[14] M. Camilleri,et al. Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders. , 2006, Gastroenterology.
[15] N. Talley,et al. A placebo-controlled trial of itopride in functional dyspepsia. , 2006, The New England journal of medicine.
[16] D. Forman,et al. Pharmacological interventions for non-ulcer dyspepsia. , 2006, The Cochrane database of systematic reviews.
[17] A. Zinsmeister,et al. Functional dyspepsia, delayed gastric emptying, and impaired quality of life , 2005, Gut.
[18] T. Ohkusa,et al. Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review , 2005, Journal of Gastroenterology.
[19] J. Vandenberghe,et al. Dyspeptic patients with visceral hypersensitivity: sensitisation of pain specific or multimodal pathways? , 2005, Gut.
[20] M. Asaka,et al. Randomized, double‐blind, placebo‐controlled crossover trial of famotidine in patients with functional dyspepsia , 2005, Alimentary pharmacology & therapeutics.
[21] H. Seno,et al. Usefulness of famotidine in functional dyspepsia patient treatment: comparison among prokinetic, acid suppression and antianxiety therapies , 2005, Alimentary pharmacology & therapeutics.
[22] J. Tack,et al. Pathophysiology and treatment of functional dyspepsia. , 2005, Journal of clinical gastroenterology.
[23] G. Triadafilopoulos,et al. A prospective study of oesophageal 24-h ambulatory pH monitoring in patients with functional dyspepsia. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[24] D. Amarapurkar,et al. Randomised, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia. , 2004, Journal of the Indian Medical Association.
[25] D. Forman,et al. The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis. , 2004, Gastroenterology.
[26] H. El‐Serag,et al. The Prevalence and Risk Factors of Functional Dyspepsia in a Multiethnic Population in the United States , 2004, The American Journal of Gastroenterology.
[27] F. Mearin,et al. Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[28] P. Moayyedi,et al. The methodological quality of trials affects estimates of treatment efficacy in functional (non‐ulcer) dyspepsia , 2004, Alimentary pharmacology & therapeutics.
[29] D. Drossman. Psychosocial Factors and the Disorders of GI Function: What is the Link? , 2004, American Journal of Gastroenterology.
[30] N. Kinukawa,et al. Treating Nonulcer Dyspepsia Considering Both Functional Disorders of the Digestive System and Psychiatric Conditions , 1998, Digestive Diseases and Sciences.
[31] Chi-Sen Chang,et al. Effect of fluoxetine on symptoms and gastric dysrhythmia in patients with functional dyspepsia. , 2003, Hepato-gastroenterology.
[32] M. Yuen,et al. Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients , 2002, Gut.
[33] G. Holtmann,et al. A randomized placebo‐controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia , 2002, Alimentary pharmacology & therapeutics.
[34] R. Hunt. Evolving concepts in the pathophysiology of functional gastrointestinal disorder. , 2002, Journal of clinical gastroenterology.
[35] A. Morelli,et al. Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia , 2002, Alimentary pharmacology & therapeutics.
[36] J. Hartung,et al. Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies. , 2001, Scandinavian journal of gastroenterology.
[37] N. Talley,et al. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis , 2001, American Journal of Gastroenterology.
[38] M. Camilleri,et al. Visceral hypersensitivity: facts, speculations, and challenges , 2001, Gut.
[39] N. Talley,et al. Failure of a motilin receptor agonist (ABT‐229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double‐blind placebo‐controlled trial , 2000, Alimentary pharmacology & therapeutics.
[40] A. Blum,et al. Short course acid suppressive treatment for patients with functional dyspepsia: results depend onHelicobacter pyloristatus , 2000, Gut.
[41] V. Savarino,et al. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis , 2000, Alimentary pharmacology & therapeutics.
[42] P. O'Malley,et al. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. , 2000, The American journal of medicine.
[43] D. Drossman,et al. Psychosocial aspects of the functional gastrointestinal disorders , 1999, Gut.
[44] M. Camilleri,et al. Functional gastroduodenal disorders , 1999, Gut.
[45] G. Tougas,et al. Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: findings from the DIGEST study. Domestic/International Gastroenterology Surveillance Study. , 1999, The American journal of gastroenterology.
[46] R. Fisher,et al. Management of nonulcer dyspepsia. , 1998, The New England journal of medicine.
[47] Talley,et al. Efficacy of omeprazole in functional dyspepsia: double‐blind, randomized, placebo‐controlled trials (the Bond and Opera studies) , 1998, Alimentary pharmacology & therapeutics.
[48] A. Andriulli,et al. Patterns of symptoms in functional dyspepsia: role of Helicobacter pylori infection and delayed gastric emptying , 1998, American Journal of Gastroenterology.
[49] K. Olden. Are psychosocial factors of aetiological importance in functional dyspepsia? , 1998, Bailliere's clinical gastroenterology.
[50] M. Hughes,et al. Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia. , 1998, Journal of clinical gastroenterology.
[51] J. Hyun,et al. Effects of Levosulpiride in Patients with Functional Dyspepsia Accompanied by Delayed Gastric Emptying , 1998, The Korean journal of internal medicine.
[52] S. Fullerton,et al. Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. , 1998, The American journal of gastroenterology.
[53] A. Sonnenberg,et al. AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. , 1998, Gastroenterology.
[54] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.
[55] M. Teh,et al. Effect of cisapride on functional dyspepsia in patients with and without histological gastritis: A double‐blind placebo‐controlled trial , 1997, Journal of gastroenterology and hepatology.
[56] E A Mayer,et al. Regional cerebral activity in normal and pathological perception of visceral pain. , 1997, Gastroenterology.
[57] N. Talley,et al. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. , 1996, The American journal of gastroenterology.
[58] U. Malt,et al. A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin. , 1996, Scandinavian journal of gastroenterology.
[59] N. Talley. Quality of life in functional dyspepsia. , 1996, Scandinavian journal of gastroenterology. Supplement.
[60] O. Nyrén,et al. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. , 1995, Gastroenterology.
[61] N. Talley. Non‐ulcer dyspepsia: myths and realities , 1991, Alimentary pharmacology & therapeutics.
[62] N. Talley. Spectrum of chronic dyspepsia in the presence of the irritable bowel syndrome. , 1991, Scandinavian journal of gastroenterology. Supplement.
[63] M. Comberlato,et al. Drug Treatment of Functional Dyspepsia: A Meta‐Analysis of Randomized Controlled Clinical Trials , 1989, Journal of clinical gastroenterology.
[64] MANAGEMENT OF DYSPEPSIA: REPORT OF A WORKING PARTY , 1988, The Lancet.
[65] L. Miller,et al. Dyspepsia, antral motor dysfunction, and gastric stasis of solids. , 1980, Gastroenterology.